Monitoring Vancomycin Levels with a New Test
Author Information
Author(s): Galvidis Inna A., Surovoy Yury A., Sharipov Vitaly R., Sobolev Pavel D., Burkin Maksim A., Lipman Jeffrey
Primary Institution: I. Mechnikov Research Institute for Vaccines and Sera
Hypothesis
Can a new immunoassay tool improve the therapeutic monitoring of vancomycin levels in patients?
Conclusion
The developed immunoassay tool effectively measures vancomycin levels and is suitable for therapeutic monitoring in critically ill patients.
Supporting Evidence
- The assay showed good agreement with LC-MS/MS results.
- ACN deproteinization provided reliable VCM recovery rates.
- The developed test is cost-effective and easy to use.
- Suboptimal vancomycin exposure was observed in critically ill patients.
Takeaway
Doctors can use a new test to check how much vancomycin is in a patient's blood, helping them give the right amount of medicine.
Methodology
The study developed an ELISA tool for vancomycin monitoring and tested it on serum samples from critically ill patients.
Potential Biases
Potential interference from other substances in patient serum was examined, but the developed assay showed good specificity.
Limitations
The study did not perform targeted pharmacokinetic analysis for vancomycin due to sampling time points not being specifically matched.
Participant Demographics
Patients included critically ill individuals with extensive burn injuries.
Statistical Information
Confidence Interval
90% CI (3.1–4.6)
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website